Overview

Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide

Status:
Completed
Trial end date:
2006-04-12
Target enrollment:
Participant gender:
Summary
To determine the percentage of patients and number of cycles in which a packed red blood cell transfusion was administered due to anemia and in which antibiotics were administered due to neutropenic fever.
Phase:
N/A
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Amgen
Treatments:
Darbepoetin alfa
Doxorubicin
Ifosfamide
Isophosphamide mustard
Liposomal doxorubicin